AnalystsDaniel MarkowitzDaniel Markowitz's Stock Forecasts
AnalystsDaniel Markowitz
Analyst Ranking
Bottom 11%
#4697 out of 5229 analysts
Average Return
-5.51%
Win Rate
30%7 out of 23
Risk vs Reward
Poor
Good
Daniel Markowitz's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Guardant Health IncGH | +60.58% | $63.44 | $101.87 | 2025-10-06 - 2026-01-05 | Buy |
Natera IncNTRA | +42.14% | $138.00 | $196.15 | 2025-07-27 - 2026-03-26 | Buy |
Guardant Health IncGH | +10.24% | $92.41 | $101.87 | 2025-10-29 - 2026-01-05 | Buy |
West Pharmaceutical Services IncWST | +7.43% | $230.95 | $248.12 | 2026-02-02 - 2026-03-26 | Buy |
Bio Techne CorpTECH | +6.49% | $59.19 | $63.03 | 2025-10-06 - 2026-01-05 | Buy |
Daniel Markowitz Analyst Color
Get additional color on Daniel Markowitz's coverage of popular stocks
Daniel Markowitz's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Natera IncNTRA | 3 | Buy | $260.00 | +32.55% | Maintains | a month ago |
Transmedics Group IncTMDX | 2 | Buy | $170.00 | +66.34% | Maintains | a month ago |
Repligen CorpRGEN | 5 | Buy | $170.00 | +48.58% | Maintains | a month ago |
Guardant Health IncGH | 4 | Hold | $110.00 | +24.86% | Maintains | a month ago |
Insulet CorpPODD | 2 | Buy | $340.00 | +55.88% | Maintains | a month ago |
Bio Techne CorpTECH | 4 | Hold | $68.00 | +29.03% | Maintains | 2 months ago |
West Pharmaceutical Services IncWST | 4 | Buy | $320.00 | +28.97% | Maintains | 2 months ago |
Rambus IncRMBS | 3 | Buy | $119.00 | +30.14% | Maintains | 2 months ago |
Dexcom IncDXCM | 1 | Hold | $68.00 | +2.89% | Initiates Coverage On | 4 months ago |
Inspire Medical Systems IncINSP | 2 | Buy | $125.00 | +147.77% | Maintains | 6 months ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.